abc biopplys unique 3D in chip assays support pharma and biotech companies to improve the predictiveness of their preclinical studies and de-risk their drug discovery process. Its proprietary 3D CoSeedis™ multi-organoid technology has boosted the relevance of in vitro testing to the ex vivo level.